PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology, The University of Oxford, Mansfield Road, Oxford, UK.\', \'School of Biomedical Sciences, The University of Queensland, Brisbane, Australia.\', \'Sechenov First Moscow State Medical University, Moscow, Russia.\', \'Institute of General Pathology and Pathophysiology, Moscow, Russia.\', \'Department of Pharmacology, The University of Oxford, Mansfield Road, Oxford, UK. daniel.anthony@pharm.ox.ac.uk.\', \'Sechenov First Moscow State Medical University, Moscow, Russia. daniel.anthony@pharm.ox.ac.uk.\', \'University of Southern Denmark, Odense, Denmark. daniel.anthony@pharm.ox.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12974-021-02357-y
?:hasPublicationType
?:journal
  • Journal of neuroinflammation
is ?:pmid of
?:pmid
?:pmid
  • 34991643
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.336
?:rankingScore_hIndex
  • 83
is ?:relation_isRelatedTo_publication of
?:title
  • Nafamostat reduces systemic inflammation in TLR7-mediated virus-like illness.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34991643>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34991643>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all